<DOC>
	<DOCNO>NCT00966901</DOCNO>
	<brief_summary>An evaluation effect UV exposure follow use new nicotine patch .</brief_summary>
	<brief_title>Photoirritation Photoallergic Potential New Nicotine Patch</brief_title>
	<detailed_description>An evaluation phototoxic potential newly develop nicotine patch single dose application follow UV exposure , evaluation photoallergenic potential new nicotine patch multiple dose application follow UV exposure .</detailed_description>
	<mesh_term>Nicotine</mesh_term>
	<criteria>Healthy male females 18 65 year . Heavy smoker ( 10 cigarette per day ) willing reduce number cigarette smoke course study . Having febrile infectious illness least seven day prior first administration investigational product . Women practice one combination follow method birth control : hormonal contraceptive , condom , sponge , foam , jelly , diaphragm , intrauterine device , woman surgically sterilize . Subjects normal skin without excessive hair growth test area baseline score skin reaction assessment `` 0 '' test area . Skin type I , II , III accord Fitzpatrick . Evaluable MED ( low dose produce mild erythema visible border ) UVB . Evidence personally sign date informed consent document indicate subject inform pertinent aspect trial . Subjects willing comply schedule visit , treatment plan trial procedure . Any visible skin disorder , abnormal skin pigmentation , fissure injury skin , , opinion investigator , would interfere result trial . History dermatological disease medical condition ( particular , immunosuppression ) could , opinion investigator , preclude topical application investigational product and/or interfere evaluation test site reaction . History clinically relevant psoriasis , chronic dermatitis urticaria . Clinically relevant abnormal finding physical examination . Pregnant ( verify betaHCGtest urine ) and/or nursing woman . Any suspicion evidence current alcohol drug abuse history alcohol drug abuse within last three year . Any current past history chronic recurrent metabolic , renal , hepatic , pulmonary , gastrointestinal , neurological , endocrinological ( include pheochromocytoma ) , immunological , psychiatric cardiovascular disease , myopathy , epileptic seizure bleed tendency . Recent myocardial infarct ( within last 3 month ) , unstable deteriorate angina pectoris , coronary artery vasospasm ( Prinzmetal 's angina ) , serious cardiac arrhythmia , acute stroke . History myopathy epileptic seizure . Use medication within four week prior first treatment trial , , opinion investigator , may influence trial result safety subject . Use systemic topical analgesic antihistamine within 72 hour prior trial enrollment ( except paracetamol ) systemic topical corticosteroid within three week trial enrollment . Subjects use nicotine product cigarette within three month precede trial . Participation treatment phase clinical trial within 30 day prior treatment phase trial , within 10 time respective elimination halflife investigational drug . Subjects avoid , throughout duration trial , swimming , wash low back ( i.e. , area patch and/or irradiate study ) , usage sauna intense physical activity might result excessive sweating . Any history drug hypersensitivity , asthma , urticaria , severe allergic diathesis well current hay fever . Known sensitivity adhesive tape . Known sensitivity component test product . History irritation topically applied product .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>